Synbiobeta brings together synthetic biology’s leading community of innovators, investors, engineers, entrepreneurs, scientists, thought leaders, policy makers and academics.
The conference is designed to provide powerful business opportunities for those currently building with biology and serve as a field trip to the future for those still defining their bio-strategy.
What to expect:
Our CEO Dr Mark Kotter will be speaking about 'Synbio v2.0 - Revolutionising Medicine with the Next Disruptive Technology - Human Cells' in a Fireside Chat on Tuesday 12 April at 4:40pm PST.
Don't forget to visit booth number 12 to meet our team.